Post-IPO Equity Companies in South San Francisco

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.